Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Voice ; 33(2): 159-161, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29307768

RESUMO

OBJECTIVES: Botulinum toxin A (BtxA) injection is the mainstay treatment for laryngeal dystonias. BtxA product labeling states that reconstituted toxin should be used within 4 hours on a single patient despite several studies that have demonstrated multidose BtxA to be safe and effective. Many insurance carriers mandate the use of an outside pharmacy which necessitates a single-use approach. This study compares the cost savings of multidose BtxA for laryngeal dystonia compared to single-use. STUDY DESIGN: This is a retrospective review and projected cost savings analysis. METHODS: Records and billing information were reviewed for patients receiving BtxA for intralaryngeal injection at a single laryngology division in 2015. Inclusion criteria included CPT 64617 or J0585; exclusion criteria included CPT 64616. The price of BtxA 100 unit vial for calculation was $670. RESULTS: A total of 142 patients were seen for intralaryngeal BtxA injection resulting in 337 visits over 1 year. The average BtxA dose per visit was 2.86 units with an average of 3.06 procedure visits per year. The calculated cost of BtxA treatment using a single vial approach was found to be $2,050 per patient per year. If billed instead for $7/unit with 5 units wastage charge per visit, the yearly per patient charge is $168. Single vial-use of BtxA injection thus represents a 1,118% price increase versus multidose use. When estimated for yearly prevalence of spasmodic dysphonia, multidose BtxA use would save almost $100 million annually. CONCLUSIONS: Multidose botulinum toxin A application utilizing per unit billing is significantly less expensive than per single-use vial billing and would save the health-care system significant amount of money without any sacrifice in safety or effectiveness.


Assuntos
Inibidores da Liberação da Acetilcolina/administração & dosagem , Inibidores da Liberação da Acetilcolina/economia , Toxinas Botulínicas Tipo A/administração & dosagem , Toxinas Botulínicas Tipo A/economia , Custos de Medicamentos , Distúrbios Distônicos/tratamento farmacológico , Distúrbios Distônicos/economia , Doenças da Laringe/tratamento farmacológico , Doenças da Laringe/economia , Laringe/efeitos dos fármacos , Adulto , Idoso , Idoso de 80 Anos ou mais , Redução de Custos , Análise Custo-Benefício , Esquema de Medicação , Embalagem de Medicamentos/economia , Distúrbios Distônicos/diagnóstico , Distúrbios Distônicos/fisiopatologia , Feminino , Humanos , Injeções , Doenças da Laringe/diagnóstico , Doenças da Laringe/fisiopatologia , Laringe/fisiopatologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
Ann Thorac Surg ; 104(1): 308-312, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28483151

RESUMO

BACKGROUND: Dysphagia, aspiration, and potential pneumonia represent a major source of morbidity in patients undergoing lung transplantation. Conditions that potentiate dysphagia and aspiration include frailty and prolonged intubation. Our group of speech-language pathologists has been actively involved in performance of a bedside evaluation of swallowing, and instrumental evaluation of swallowing with modified barium swallow, and postoperative management in patients undergoing lung transplantation. METHODS: All lung transplant patients from April 2009 to September 2012 were evaluated retrospectively. A clinical bedside examination was performed by the speech-language pathology team, followed by a modified barium swallow or fiberoptic endoscopic evaluation of swallowing. RESULTS: A total of 321 patients were referred for evaluation. Twenty-four patients were unable to complete the evaluation. Clinical signs of aspiration were apparent in 160 patients (54%). Deep laryngeal penetration or aspiration were identified in 198 (67%) patients during instrumental testing. A group of 81 patients (27%) had an entirely normal clinical examination, but were found to have either deep penetration or aspiration. CONCLUSIONS: The majority of patients aspirate after lung transplantation. Clinical bedside examination is not sensitive enough and will fail to identify patients with silent aspiration. A standard of practice following lung transplantation has been established that helps avoid postoperative aspiration associated with complications.


Assuntos
Transtornos de Deglutição/diagnóstico , Deglutição/fisiologia , Transplante de Pulmão/efeitos adversos , Complicações Pós-Operatórias , Adulto , Idoso , Transtornos de Deglutição/etiologia , Transtornos de Deglutição/fisiopatologia , Endoscopia do Sistema Digestório , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem
3.
J Paediatr Child Health ; 52(5): 506-11, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27144642

RESUMO

AIM: Concurrence between parents' information needs and clinicians' practice when diagnosing autism is unknown but may influence families' uptake of management and adjustment. We aimed to compare parents' experience and preferences with paediatrician report of (i) diagnosis delivery and (ii) information given at diagnosis and identify types and usefulness of resources accessed by families post-diagnosis. METHODS: The design used for the study are parent and paediatrician surveys. Participants are parents of children aged 1.5-18 years, diagnosed with autism between 01 January 2010 and 30 September 2012 and their paediatricians who are members of the Australian Paediatric Research Network. Study-designed quantitative and qualitative questions about diagnosis delivery and information given at diagnosis (written and spoken vs. neither) and parent perceived importance and harms of information accessed post-diagnosis. RESULTS: Paediatricians (53/198 (27%)) identified 1127 eligible families, of whom 404 (36%) participated. Parents were more likely to report receiving adequate time to discuss diagnosis than paediatricians (71 vs. 51%). Parents (98%) rated information about accessing allied health professionals and the meaning of diagnosis as most important, yet paediatricians offered written or spoken information about each infrequently (allied health: 22%; diagnosis: 42%). Post-diagnosis, allied health was the most important source of information (83%). Harmful resources conveyed helplessness or non-evidenced-based therapies, but few parents (14%) reported this. CONCLUSIONS: Parents want more information than can be conveyed in a single diagnostic consultation. Developing a tailored 'autism action plan' with written materials could improve parents' understanding of and satisfaction with children's autism diagnoses.


Assuntos
Transtorno Autístico/diagnóstico , Necessidades e Demandas de Serviços de Saúde , Pais/psicologia , Pediatria , Adolescente , Adulto , Austrália , Criança , Pré-Escolar , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Lactente , Masculino
4.
Otolaryngol Head Neck Surg ; 150(4): 582-6, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24496740

RESUMO

OBJECTIVE: (1) Compare tolerance of aerosolized spray versus syringe administration of topical anesthesia for transnasal flexible laryngoscopy (TFL), (2) analyze cost-effectiveness of both techniques. STUDY DESIGN: Prospective, blinded, randomized trial. SETTING: Tertiary academic laryngology practice. METHODS: One hundred and eight patients underwent TFL over 3 months. Patients were randomized to receive equivalent dose 1:1 neosynephrine/4% plain lidocaine mixture via aerosolized spray ("spray") or application with 1-cc syringe ("syringe"). Patients and physicians independently rated comfort of TFL on 5-point scale (1 = not at all comfortable to 5 = very comfortable). Data were collected on patient and endoscopist experience with TFL and reasons for poor tolerance of laryngoscopy. Cost analyses of disposable spray tips and syringes were calculated. RESULTS: Both patients and physicians reported very high tolerance of TFL. Patient tolerance appears to be similar between spray- versus syringe-administered anesthesia, although study limitations preclude definitive analysis. Poor tolerance of laryngoscopy was reported in 6.5% with comparable distribution between anesthetic delivery methods. There was no impact of patient prior experience with TFL, and there was no difference between anesthetic methods for TFL performed by resident, fellow, or attending. The difference between costs of the disposable spray tip versus syringe was $1.32 per unit. CONCLUSIONS: Use of a 1-cc syringe is an effective method to provide topical nasal anesthesia for TFL and saves $1.32 per unit compared to disposable spray tips. In our practice, transition to syringe-administered nasal anesthesia is projected to save $1300 per 1000 patients, or an anticipated $1000 per year per physician, with excellent patient tolerance of TFL.


Assuntos
Anestesia Local/economia , Anestesia Local/métodos , Laringoscopia/métodos , Lidocaína/administração & dosagem , Sprays Nasais , Administração Intranasal , Adulto , Idoso , Anestésicos Locais/administração & dosagem , Anestésicos Locais/economia , Análise Custo-Benefício , Feminino , Tecnologia de Fibra Óptica , Humanos , Injeções Intralesionais/economia , Laringoscópios , Laringoscopia/instrumentação , Lidocaína/economia , Masculino , Pessoa de Meia-Idade , Cavidade Nasal/efeitos dos fármacos , Medição da Dor/efeitos dos fármacos , Satisfação do Paciente , Estudos Prospectivos , Método Simples-Cego , Seringas/economia
5.
N C Med J ; 73(4): 270-3, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23033712

RESUMO

Building healthy communities is critical to reducing the rates of chronic diseases impacting millions of North Carolinians. In 2011, North Carolina's overall health status ranking was 32nd in the nation (with 1 being the best). It is well recognized that health is impacted by a variety of individual, social, environmental, and economic factors, which are complex, interrelated, and influenced by a variety of other factors. Creating healthy communities provides options for people to make health-promoting choices. Such communities include transportation alternatives, access to healthy foods and places to be active, opportunities for economic growth and education, and clean air and water. Creating communities that provide these types of options requires the work of different sectors, many of which may not have health as their main mission, such as those that focus on commerce, planning, transportation, and environmental and natural resources. This article outlines the need for healthier communities and highlights the innovative partnerships and work being done by individuals and agencies at the state, local, and national levels to build healthier communities across North Carolina.


Assuntos
Doença Crônica/prevenção & controle , Planejamento em Saúde Comunitária/organização & administração , Promoção da Saúde/organização & administração , Relações Interinstitucionais , Saúde Pública , Comitês Consultivos , Humanos , Avaliação das Necessidades , North Carolina
6.
N C Med J ; 73(4): 278-80, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23033714

RESUMO

To thrive economically, North Carolina needs a healthy, productive workforce. The public and private sectors should collaborate on the prevention and management of chronic diseases, which significantly impact the state's economy. Evidence-based prevention strategies should be prioritized, and communities should be designed with public health considerations in mind.


Assuntos
Doença Crônica/prevenção & controle , Comércio , Planejamento em Saúde Comunitária/organização & administração , Promoção da Saúde/organização & administração , Relações Interinstitucionais , Saúde Pública , Humanos , North Carolina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA